Creo Medical Group PLC

Description

Creo Medical Group Plc is an UK-based medical device company, founded in 2003 initially focused on the treatment of cancers by high frequency microwave energy and matching techniques. Its headquarters are in the United Kingdom. The company engaged in the business of the development and commercialization nominal invasive surgical devices, originally around gastrointestinal (GI) surgery and lung cancer. The company’s focus is on the area of surgical endoscopy. The company offers various product include CROMA, Speedboat Inject, MicroBlate Fine, SlypSeal Flex, Speedboat Slim, MicroBlate Flex, SpydrBlade Flex and after sales support.

The company has developed an advanced Energy Platform known as CROMA, it is an electrosurgical platform that delivers bipolar radiofrequency and microwave energy by a single accessory port. CROMA is a surgical system of the company through which it combines bipolar radiofrequency and microwave energy for localized cutting and controlled coagulation that gives simplified and controlled surgical solutions to physicians. The company’s main portfolio of devices include three therapeutic endoscopic specialties are lower GI, upper GI and lung/bronchoscopy.

The company established structure distribution agreements for several regions including the UK, USA, European markets, South Africa, the Asia-Pacific to give a route to its devices in multiple countries all over the world. The company’s Speedboat device is first of its GI endoscopic devices received a CE-mark for FDA clearance, UK, and Europe. The company’s aim is to better patient result through using surgical endoscopy including microwave and radiofrequency energy